Mallat MJK - Search Results

1

Acute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular Injury.

Bijkerk R, Florijn BW, Khairoun M, Duijs JMGJ, Ocak G, de Vries APJ, Schaapherder AF, Mallat MJK, de Fijter JW, Rabelink TJ, van Zonneveld AJ, Reinders MEJ. Bijkerk R, et al. Among authors: mallat mjk. Transplant Direct. 2017 Jun 19;3(7):e174. doi: 10.1097/TXD.0000000000000699. eCollection 2017 Jul. Transplant Direct. 2017. PMID: 28706977 Free PMC article.

2

Sharing cross-reactive groups of MHC class I improves long-term graft survival.

Sijpkens YW, Doxiadis II, De Fijter JW, Mallat MJ, van Es LA, De Lange P, Zwinderman AH, Westendorp RG, van Kemenade FJ, Bruijn JA, Claas FH, Paul LC. Sijpkens YW, et al. Kidney Int. 1999 Nov;56(5):1920-7. doi: 10.1046/j.1523-1755.1999.00753.x. Kidney Int. 1999. PMID: 10571803 Free article.

3

Delayed graft function influences renal function, but not survival.

Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Boom H, et al. Kidney Int. 2000 Aug;58(2):859-66. doi: 10.1046/j.1523-1755.2000.00235.x. Kidney Int. 2000. PMID: 10916111 Free article.

4

Delayed graft function influences renal function but not survival.

Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Boom H, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1291. doi: 10.1016/s0041-1345(00)02482-9. Transplant Proc. 2001. PMID: 11267296 No abstract available.

5

Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.

Sijpkens YW, Mallat MJ, Siegert CE, Zwinderman AH, Westendorp RG, de Fijter JW, van Es LA, Paul LC. Sijpkens YW, et al. Clin Nephrol. 2001 Feb;55(2):149-55. Clin Nephrol. 2001. PMID: 11269679

6

Early versus late acute rejection episodes in renal transplantation.

Sijpkens YW, Doxiadis II, Mallat MJ, de Fijter JW, Bruijn JA, Claas FH, Paul LC. Sijpkens YW, et al. Transplantation. 2003 Jan 27;75(2):204-8. doi: 10.1097/01.TP.0000041722.34000.21. Transplantation. 2003. PMID: 12548124

7

Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy.

Bakker RC, Hollander AA, Mallat MJ, Bruijn JA, Paul LC, de Fijter JW. Bakker RC, et al. Kidney Int. 2003 Sep;64(3):1027-34. doi: 10.1046/j.1523-1755.2003.00175.x. Kidney Int. 2003. PMID: 12911553 Free article. Clinical Trial.

8

Calcium levels as a risk factor for delayed graft function.

Boom H, Mallat MJ, de Fijter JW, Paul LC, Bruijn JA, van Es LA. Boom H, et al. Transplantation. 2004 Mar 27;77(6):868-73. doi: 10.1097/01.tp.0000116417.03114.87. Transplantation. 2004. PMID: 15077029

9

An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.

van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR. van der Boog PJ, et al. Nephrol Dial Transplant. 2004 Oct;19(10):2487-93. doi: 10.1093/ndt/gfh394. Epub 2004 Jul 13. Nephrol Dial Transplant. 2004. PMID: 15252166

10

Association between mannose-binding lectin levels and graft survival in kidney transplantation.

Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Berger SP, et al. Am J Transplant. 2005 Jun;5(6):1361-6. doi: 10.1111/j.1600-6143.2005.00841.x. Am J Transplant. 2005. PMID: 15888042 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page